COGNITION THERAPEUTICS INC insider trading

CGTXNASDAQ

$0.93+0.03 (+3.82%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-35.3%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Unlock quarterly net flow

Key players

AGAaron G.l. FletcherDirector6.3687%of company
LRLisa RicciardiCEO & President1.8452%of company
ACAnthony CaggianoChief Medical Officer0.92%of company
JBJohn Brendan DoyleChief Financial Officer0.6509%of company
PWPeggy WallaceDirector0.1172%of company
EBEllen B. RichstoneDirector0.0878%of company
BPBrett P. MoniaDirector0.0773%of company
JAJack A. KhattarDirector0.0773%of company
BMBIOS Memory SPV I, LPDirectorNot reportedof company
BABIOS Advisors GP, LLCDirectorNot reportedof company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
CGTX	John Brendan DoyleChief Financial Officer	Open market purchase$11.3K	+1.6%	$1.13	$11.3K	Apr 16, 2026	Apr 20, 2026
CGTX	Lisa RicciardiCEO & President	Open market purchase$10.1K	+0.5%	$1.10	$10.1K	Apr 16, 2026	Apr 20, 2026
CGTX	Anthony CaggianoChief Medical Officer	Open market purchase$11.1K	+1.2%	$1.11	$11.1K	Apr 16, 2026	Apr 20, 2026

End of history · 3 transactions